These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
641 related articles for article (PubMed ID: 21689417)
21. Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway. Zhu Y; Qiu Z; Zhang X; Qian F; Wang B; Wang L; Shi H; Yu R J Neurooncol; 2017 Jan; 131(1):31-39. PubMed ID: 27640199 [TBL] [Abstract][Full Text] [Related]
22. Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5. Wang S; Pan Y; Zhang R; Xu T; Wu W; Zhang R; Wang C; Huang H; Calin CA; Yang H; Claret FX Oncogene; 2016 Nov; 35(47):6096-6108. PubMed ID: 27157611 [TBL] [Abstract][Full Text] [Related]
23. Transcriptional activation of the mouse obese (ob) gene by CCAAT/enhancer binding protein alpha. Hwang CS; Mandrup S; MacDougald OA; Geiman DE; Lane MD Proc Natl Acad Sci U S A; 1996 Jan; 93(2):873-7. PubMed ID: 8570651 [TBL] [Abstract][Full Text] [Related]
24. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity. Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108 [TBL] [Abstract][Full Text] [Related]
25. Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation. Kim BC; Lee HJ; Park SH; Lee SR; Karpova TS; McNally JG; Felici A; Lee DK; Kim SJ Mol Cell Biol; 2004 Mar; 24(6):2251-62. PubMed ID: 14993265 [TBL] [Abstract][Full Text] [Related]
26. CCAAT/enhancer-binding proteins beta and delta mediate the repression of gene transcription of cartilage-derived retinoic acid-sensitive protein induced by interleukin-1 beta. Okazaki K; Li J; Yu H; Fukui N; Sandell LJ J Biol Chem; 2002 Aug; 277(35):31526-33. PubMed ID: 12072435 [TBL] [Abstract][Full Text] [Related]
27. Characterization of a unique motif in LIM mineralization protein-1 that interacts with jun activation-domain-binding protein 1. Sangadala S; Yoshioka K; Enyo Y; Liu Y; Titus L; Boden SD Mol Cell Biochem; 2014 Jan; 385(1-2):145-57. PubMed ID: 24078030 [TBL] [Abstract][Full Text] [Related]
28. C/EBPbeta and GATA-1 synergistically regulate activity of the eosinophil granule major basic protein promoter: implication for C/EBPbeta activity in eosinophil gene expression. Yamaguchi Y; Nishio H; Kishi K; Ackerman SJ; Suda T Blood; 1999 Aug; 94(4):1429-39. PubMed ID: 10438731 [TBL] [Abstract][Full Text] [Related]
29. The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Schumann RR; Kirschning CJ; Unbehaun A; Aberle HP; Knope HP; Lamping N; Ulevitch RJ; Herrmann F Mol Cell Biol; 1996 Jul; 16(7):3490-503. PubMed ID: 8668165 [TBL] [Abstract][Full Text] [Related]
30. Jab1 is overexpressed in human breast cancer and is a downstream target for HER-2/neu. Hsu MC; Chai CY; Hou MF; Chang HC; Chen WT; Hung WC Mod Pathol; 2008 May; 21(5):609-16. PubMed ID: 18246048 [TBL] [Abstract][Full Text] [Related]
31. CCAAT/enhancer-binding protein isoforms beta and delta are expressed in mammary epithelial cells and bind to multiple sites in the beta-casein gene promoter. Doppler W; Welte T; Philipp S J Biol Chem; 1995 Jul; 270(30):17962-9. PubMed ID: 7629103 [TBL] [Abstract][Full Text] [Related]
32. A novel RBP-J kappa-dependent switch from C/EBP beta to C/EBP zeta at the C/EBP binding site on the C-reactive protein promoter. Singh PP; Voleti B; Agrawal A J Immunol; 2007 Jun; 178(11):7302-9. PubMed ID: 17513780 [TBL] [Abstract][Full Text] [Related]
33. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation. Cortez DM; Feldman MD; Mummidi S; Valente AJ; Steffensen B; Vincenti M; Barnes JL; Chandrasekar B Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3356-65. PubMed ID: 17921324 [TBL] [Abstract][Full Text] [Related]
34. Relative roles of CCAAT/enhancer-binding protein beta and cAMP regulatory element-binding protein in controlling transcription of the gene for phosphoenolpyruvate carboxykinase (GTP). Park EA; Gurney AL; Nizielski SE; Hakimi P; Cao Z; Moorman A; Hanson RW J Biol Chem; 1993 Jan; 268(1):613-9. PubMed ID: 8093246 [TBL] [Abstract][Full Text] [Related]
35. c-Jun Contributes to Transcriptional Control of GNA12 Expression in Prostate Cancer Cells. Udayappan UK; Casey PJ Molecules; 2017 Apr; 22(4):. PubMed ID: 28394299 [No Abstract] [Full Text] [Related]
36. Transcriptional regulation of the human reduced folate carrier promoter C: synergistic transactivation by Sp1 and C/EBP beta and identification of a downstream repressor. Payton SG; Whetstine JR; Ge Y; Matherly LH Biochim Biophys Acta; 2005 Jan; 1727(1):45-57. PubMed ID: 15652157 [TBL] [Abstract][Full Text] [Related]
37. Interleukin-6-induced tethering of STAT3 to the LAP/C/EBPbeta promoter suggests a new mechanism of transcriptional regulation by STAT3. Niehof M; Streetz K; Rakemann T; Bischoff SC; Manns MP; Horn F; Trautwein C J Biol Chem; 2001 Mar; 276(12):9016-27. PubMed ID: 11114305 [TBL] [Abstract][Full Text] [Related]
38. PU.1 (Spi-1) and C/EBP alpha regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene. Hohaus S; Petrovick MS; Voso MT; Sun Z; Zhang DE; Tenen DG Mol Cell Biol; 1995 Oct; 15(10):5830-45. PubMed ID: 7565736 [TBL] [Abstract][Full Text] [Related]
39. Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer. Nam AR; Kim JW; Park JE; Bang JH; Jin MH; Oh DY; Bang YJ Cancer Res Treat; 2019 Jul; 51(3):886-900. PubMed ID: 30282449 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer. Wang S; Oh DY; Leventaki V; Drakos E; Zhang R; Sahin AA; Resetkova E; Edgerton ME; Wu W; Claret FX Cancer Lett; 2019 Nov; 465():12-23. PubMed ID: 31473252 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]